Welcome to the home of the Quinolone Vigilance Foundation (QVF), a non-profit, charitable foundation that funds research on fluoroquinolone toxicity and helps raise awareness about their dangers among patients and medical professionals.
Fluoroquinolones are one of the most commonly prescribed classes of antibiotics. They are very powerful medications often wrongly given as a first line of defense against a wide variety of routine infections.
All antibiotics have side effects. What differentiates this class of antibiotics from others is its ability to cause severe adverse reactions that can disable patients and even cause death. You can review a list of patient-reported adverse reactions on our Quinolones 101 page .
For some, reactions to fluoroquinolones can occur from as little as one pill. For others, reactions can occur weeks, months, or even longer after taking the drugs. Often, patients and even medical professionals do not suspect that these antibiotics could be the cause, as symptoms can often mimic other medical conditions.
Approximately half of the fluoroquinolones that were once on the market have now been removed from clinical practice due to their severe toxicities. Although warnings and cautionary information exist, doctors continue to prescribe this class of antibiotics for infections they were never intended to treat. As a result, many patients continue to unnecessarily suffer devastating disabilities.
QVF believes that every fluoroquinolone prescription should be accompanied by full disclose of the risk for lifelong disability so that patients can make informed choices. To ensure that this information reaches patients, the FDA should add additional warnings to the drug packaging and finally require that a Dear Doctor letter go out to every physician in the United States, warning them of the risks to their patients.
To stay informed about the latest news, research, and patient safety information regarding fluoroquinolones, as well as QVF activities and volunteer opportunities , please subscribe using the Updates and News form to the right.
We look forward to hearing from you.
QVF President/Executive Director Rachel Brummert – guest blog about brain fog for Baron & Budd Law Firm
Quinolone Vigilance Foundation’s President/Executive Director Rachel Brummert wrote a guest blog about brain fog for Baron & Budd Law Firm.
Request for FDA to Investigate Potential Levaquin Link to “Mystery Illnesses” in California Children
Quinolone Vigilance Foundation Asks the FDA To Reconsider Levaquin Use For Children
HAMILTON, N.J., Sept. 16, 2014 /PRNewswire-iReach/ — Quinolone Vigilance Foundation (QVF) has asked the FDA to investigate whether the fluoroquinolone antibiotic, Levaquin, could […]
Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox
FDA and Drug Makers Asked to Expand Warnings about Psychiatric Adverse Events Risk
HAMILTON, N.J., Sept. 15, 2014 /PRNewswire-iReach/ — On September 8, 2014, Dr. Charles Bennett, University of South Carolina, submitted a Citizen Petition […]
Quinolone Vigilance Foundation welcomes Ms Jenny Frank as Public Relations Director. She will serve as liaison between Quinolone Vigilance Foundation and the media, and writing press releases.
Quinolone Vigilance Foundation Warns Levaquin, Cipro, Avelox May Result In Neurodegenerative Diseases
FDA and Drug Makers Fail to Warn Doctors and Patients
HAMILTON, N.J., Sept. 2, 2014 /PRNewswire-iReach/ — Four years ago, Lisa was a physically active and healthy 45 year old. She would frequently unwind at […]